To determine the effect of COVID-19 convalescent plasma on mortality, we aggregated
patient outcome data from 10 randomized clinical trials, 20 matched control studies, 2 dose …

The use of antiviral COVID-19 medications can successfully inhibit SARS-CoV-2 replication
and prevent disease progression to a more severe form. However, the timing of antiviral …

COVID-19 pandemic has spread worldwide at an exponential rate affecting millions of
people instantaneously. Currently, various drugs are under investigation to treat an …

The COVID-19 pandemic has been met with an unprecedented response from the scientific
community, leading to the development, investigation, and authorization of vaccines and …

Objective To examine the association of COVID-19 convalescent plasma transfusion with
mortality and the differences between subgroups in hospitalized patients with COVID-19 …

Convalescent plasma has been used worldwide to treat patients hospitalized with
coronavirus disease 2019 (COVID-19) and prevent disease progression. Despite global …

Background Remdesivir is considered to be a specific drug for treating coronavirus disease
2019. This systematic review aims to evaluate the clinical efficacy and risk of remdesivir …

Pathogenesis SARS-CoV-2 spreads through respiratory droplet transmission as well as
contaminated objects or surfaces and enters host cells via the functional cell receptor ACE2 …

Background There is still a lack of consensus on the efficacy of convalescent plasma (CP)
treatment in COVID‐19 patients. We performed a systematic review and meta‐analysis to …

Plasma collected from people recovered from COVID-19 (COVID-19 convalescent plasma,
CCP) was the first antibody-based therapy employed to fight the pandemic. CCP was …